[HTML][HTML] A mouse keratin 1 mutation causes dark skin and epidermolytic hyperkeratosis

KA McGowan, S Aradhya, H Fuchs… - Journal of investigative …, 2006 - Elsevier
KA McGowan, S Aradhya, H Fuchs, MH de Angelis, GS Barsh
Journal of investigative dermatology, 2006Elsevier
Chemical mutagenesis in the mouse has increased the utility of phenotype-driven genetics
as a means for studying different organ systems, developmental pathways, and pathologic
processes. From a large-scale screen for dominant phenotypes in mice, a novel class of
pigmentation mutants was identified by dark skin (Dsk). We describe a Dsk mutant, Dsk12,
which models the human disease, epidermolytic hyperkeratosis (EHK). At 2 days of age,
mutant animals exhibit intraepidermal blisters and erosions at sites of trauma, and by 2 …
Chemical mutagenesis in the mouse has increased the utility of phenotype-driven genetics as a means for studying different organ systems, developmental pathways, and pathologic processes. From a large-scale screen for dominant phenotypes in mice, a novel class of pigmentation mutants was identified by dark skin (Dsk). We describe a Dsk mutant, Dsk12, which models the human disease, epidermolytic hyperkeratosis (EHK). At 2 days of age, mutant animals exhibit intraepidermal blisters and erosions at sites of trauma, and by 2 weeks of age develop significant hyperkeratosis. We identified a missense mutation in mutant animals that predicts an S194P amino acid substitution in the 1A domain of Keratin 1, a known target for human mutations that cause EHK. Dsk12 recapitulates the gross pathologic, histologic, and genetic aspects of the human disorder, EHK.
Elsevier